Regeneus makes a healthy debut

Regeneus shares rise 8 per cent on first trading day.

Shares in Regeneus Ltd., the cell-based regenerative company, has a market value of $49.6 million after the stock rose 8 per cent on its first day of trade.

The Sydney-based company, founded in August 2007 to develop and commercialise cell treatment for humans and animals, closed up 2 cents at 27 cents, after rising as high as 29 cents.

{{content.question}}

SMS Code Sent…

Hi {{ user.FirstName }}

Looks like you've already taken a free trial

Please enter your payment details

We have sent you a code via SMS to {{user.DayPhone}}

please enter this code below to activate your membership

If you didn't receive SMS code please

Looks you are already a member. Please enter your password to proceed

Please untick this box when using a public or shared device


Verify your mobile number to unlock a FREE trial

Please sign up for full access

Updating information

Please wait ...

  • Mastercard
  • Visa

Related Articles